Vertex Pharmaceuticals Incorporated (VRTX) closed at $498.5 on October 15, 2026, posting a 24-hour gain of 2.70% as buyers returned to the biotech name after recent weakness.
Despite the single-session advance, the stock remains under pressure over longer time horizons. Shares have declined 1.40% over the past seven days and are down 4.07% over the trailing 30-day period.
The company carries a market capitalization of $122.98 billion, reflecting its standing as one of the larger players in the pharmaceutical sector. The current price of $498.5 places it near a significant round-number threshold that traders have watched closely.
The broader context suggests the daily move has not been enough to fully reverse the month-long slide. Whether the session's momentum carries forward will depend on broader market conditions and company-specific developments in the days ahead.
